QSAR and 3D QSAR in drug design .1. methodology

被引:312
|
作者
Kubinyi, H
机构
[1] Drug Design, ZHV/W-A30, BASF AG
关键词
D O I
10.1016/S1359-6446(97)01079-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Classical QSAR methods describe structure-activity relationships in terms of physicochemical parameters and steric properties (Hansch analysis, extrathermodynamic approach), or certain structural features (Free Wilson analysis). 3D QSAR methods, especially comparative molecular field analysis, consider the three-dimensional structures and the binding modes of protein ligands. Quantitative similarity-activity relationships derive correlations between the similarities of individual compounds and their biological activities. Theory and methodology of these approaches are described here, together with the proper use of regression and partial least squares analyses for deriving quantitative structure-activity relationships. Part 2, to be published in the December issue, will address applications and problems.
引用
收藏
页码:457 / 467
页数:11
相关论文
共 50 条
  • [21] Structure-based 3D QSAR and design of novel acetylcholinesterase inhibitors
    Wolfgang Sippl
    Jean-Marie Contreras
    Isabelle Parrot
    Yveline M. Rival
    Camille G. Wermuth
    Journal of Computer-Aided Molecular Design, 2001, 15 : 395 - 410
  • [22] Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors
    Leonetti, F
    Favia, A
    Rao, A
    Aliano, R
    Paluszcak, A
    Hartmann, RW
    Carotti, A
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (27) : 6792 - 6803
  • [23] 3D QSAR Studies on 1, 3, 4-Thiadiazole Derivatives: An Approach to Design Novel Anticonvulsants
    Thareja, Suresh
    Aggarwal, Saurabh
    Verma, Abhilasha
    Bhardwaj, Tilak Raj
    Kumar, Manoj
    MEDICINAL CHEMISTRY, 2010, 6 (04) : 233 - 238
  • [24] Lipophilicity in drug design: an overview of lipophilicity descriptors in 3D-QSAR studies
    Ginex, Tiziana
    Vazquez, Javier
    Gilbert, Enric
    Herrero, Enric
    Luque, Francisco J.
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (10) : 1177 - 1193
  • [25] QSAR and Computer Aided Drug Design
    Khan, Mahmud Tareq Hassan
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2012, 12 (06) : 445 - 446
  • [26] QSAR IN ENVIRONMENTAL SCIENCES AND DRUG DESIGN
    HERMENS, J
    SCIENCE OF THE TOTAL ENVIRONMENT, 1991, 109 : 1 - 7
  • [27] 3D QSAR study of class I antiarrhythmics
    Borosy, AP
    Keseru, K
    Pénzes, I
    Mátyus, P
    JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 2000, 503 (1-2): : 113 - 129
  • [28] Comparative molecular active site analysis (CoMASA). 1. An approach to rapid evaluation of 3D QSAR
    Kotani, T
    Higashiura, K
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (11) : 2732 - 2742
  • [29] RECOMMENDATIONS FOR COMFA STUDIES AND 3D QSAR PUBLICATIONS
    THIBAUT, U
    FOLKERS, G
    KLEBE, G
    KUBINYI, H
    MERZ, A
    ROGNAN, D
    QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 1994, 13 (01): : 1 - 3
  • [30] 3D QSAR methods: Phase and catalyst compared
    Evans, David A.
    Doman, Thompson N.
    Thorner, David A.
    Bodkin, Michael J.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2007, 47 (03) : 1248 - 1257